Pandemic Fraud

MANHATTAN — A federal class action claims that SCWorx and its CEO falsely claimed that they had sold 2 million “Covid-19 rapid testing kits, ‘with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week,’” goosing its stock price, after which the SEC halted trading in it.

%d bloggers like this: